文献速递外周动脉疾病

表征患者报告的跛行治疗目标以支持以患者为中心的治疗选择与评估策略

Characterizing patient-reported claudication treatment goals to support patient-centered treatment selection and measurement strategies.
PubMed 文献 · J Vasc Surg · 2022-09-08

该研究前瞻性招募150例跛行患者,通过问卷量化患者自定的行走距离、时长和速度相关治疗目标,并分析患者特征与目标及外周动脉疾病特异性患者报告结局评分之间的关联。结果显示多数患者以增加无停歇行走距离或时长为目标,且其期望的最小改善幅度超过已报道的最小重要差异标准。

要点

  • 96%的跛行患者以增加无停歇行走距离或时长为主要治疗目标。
  • 患者认为有意义改善的最小距离为≥0.5英里(2640英尺)者占64%,最小时长为≥30分钟者占59%。
  • 年龄增长与设定≥0.5英里距离目标(每5年OR 0.68)和≥30分钟时长目标(每5年OR 0.76)的 odds 降低相关。

核心结论

  • 患者根据期望的活动和预期定义治疗目标,这可能影响其目标和感知结果。
  • 患者对有意义改善的最小行走距离和时长增加的期望超过了许多患者报告的微小临床重要差异标准,且常用诊所行走测试无法捕捉。
  • 患者年龄与治疗目标和患者报告结局评分均相关,相关地板和天花板效应可能分别影响年轻和老年患者对患者报告结局变化的敏感性。
  • 治疗目标的异质性支持考虑基于患者特征和视角的定制决策和结局评估。

研究设计与样本

  • 前瞻性招募诊断为跛行的患者,使用多项选择调查条目量化患者自定的行走距离、时长和速度相关治疗目标,使用自由文本条目识别与症状和治疗目标相关的其他活动。
  • 纳入外周动脉疾病生活质量问卷和行走障碍问卷作为患者报告结局,使用95%置信区间、分类检验和逻辑回归模型比较治疗目标类别与患者报告结局百分位评分,使用线性回归和有序逻辑回归模型评估患者特征与患者报告结局的关联。
  • 共纳入150例符合入选标准的患者,其中144例(96%)完成了整个调查;平均年龄70.0±11.3岁,女性占32.9%。

主要发现

  • 主要治疗目标为增加无停歇行走距离或时长者占62.0%,能够执行特定活动或任务者占23.0%,增加行走速度者占8.0%,其他或无上述目标者占7.0%。
  • 与症状或目标相关的特定活动包括户外休闲(38.5%)、劳动相关任务(30.7%)、运动(26.9%)、爬楼梯(23.1%)、上坡行走(19.2%)和购物(6%)。
  • 在选择增加行走距离和时长为主要目标的患者中,64%表示距离≥0.5英里(2640英尺)和59%表示时长≥30分钟是最小增加量才符合有意义改善。
  • 年龄增长与≥0.5英里距离改善目标的 odds 降低相关(每5年OR 0.68;95%CI 0.51-0.92;P=0.012),与≥30分钟时长改善目标的 odds 降低相关(每5年OR 0.76;95%CI 0.58-0.99;P=0.047)。
  • 与外周动脉疾病生活质量百分位评分相关的患者特征包括年龄、踝臂指数和性别;踝臂指数是唯一与行走障碍问卷百分位评分相关的患者特征。

临床怎么用

  • 患者根据期望的活动和预期定义治疗目标,可能影响其目标和感知结果。
  • 患者对有意义改善的最小行走距离和时长增加的期望超过了许多患者报告的微小临床重要差异标准,且常用诊所行走测试无法捕捉。
  • 治疗目标的异质性支持考虑基于患者特征和视角的定制决策和结局评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patient-reported outcomes (PRO) have been increasingly emphasized for peripheral artery disease (PAD). Patient-defined treatment goals and expectations, however, are poorly understood and might not be achievable or aligned with guidelines or clinical outcomes. We evaluated the patient-reported treatment goals among patients with claudication and the associations between patient characteristics, goals, and PAD-specific PRO scores. METHODS: Patients with a diagnosis of claudication were prospectively recruited. Patient-defined treatment goals and outcomes related to walking distance, duration, and speed were quantified using multiple-choice survey items. Free-text items were used to identify activities other than walking distance, duration, or speed associated with symptoms and treatment goals. The peripheral artery disease quality of life and walking impairment questionnaire instruments were included as PRO. The treatment goal categories were compared with the PRO percentile scores using 95% confidence intervals (CIs), categorical tests, and logistic regression models. Associations between the patient characteristics and PRO were evaluated using linear and ordinal logistic regression models. RESULTS: A total of 150 patients meeting the inclusion criteria were included in the present study. Of these 150 patients, 144 (96%) viewed the entire survey. Their mean age was 70.0 ± 11.3 years, and 32.9% were women. Most of the respondents had self-reported their race as White (n = 135), followed by Black (n = 3), Asian (n = 2), Native American (n = 2), and other/unknown (n = 2). Two participants self-reported Hispanic ethnicity. The primary treatment goals were an increased walking distance or duration without stopping (62.0%), the ability to perform a specific activity or task (23.0%), an increased walking speed (8.0%), or other/none of the above (7.0%). The specific activities associated with symptoms or goals included outdoor recreation (38.5%), labor-related tasks (30.7%), sports (26.9%), climbing stairs (23.1%), uphill walking (19.2%), and shopping (6%). Among the patients choosing an increased walking distance and duration as the primary goals, 64% had indicated that a distance of ≥0.5 mile (2640 ft) and 59% had indicated a duration of ≥30 minutes would be a minimum increase consistent with meaningful improvement. Increasing age was associated with lower odds of a distance improvement goal of ≥0.5 mile (odds ratio [OR], 0.68 per 5 years; 95% CI, 0.51-0.92; P = .012) or duration improvement goal of ≥30 minutes (OR, 0.76 per 5 years; 95% CI, 0.58-0.99; P = .047). Patient characteristics associated with PAD Quality of Life percentile scores included age, ankle brachial index, and gender. Ankle brachial index was the only patient characteristic associated with the walking impairment questionnaire percentile scores. CONCLUSIONS: Patients define treatment goals according to their desired activities and expectations, which may influence their goals and perceived outcomes. Patients' expectations of minimum increases in walking distance and duration consistent with meaningful improvement exceeded reported minimum important difference criteria for many patients and would not be captured using common clinic-based walking tests. Patient age was associated with both treatment goals and PRO scores, and the related floor and ceiling effects could influence sensitivity to PRO changes for younger and older patients, respectively. Heterogeneity in treatment goals supports consideration of tailored decision-making and outcomes informed by patient characteristics and perspectives.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Powell CA, Kim GY, Edwards SN, et al. Characterizing patient-reported claudication treatment goals to support patient-centered treatment selection and measurement strategies. J Vasc Surg. 2022. PMID: 36087833. doi:10.1016/j.jvs.2022.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。